DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+1.33%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.76B
AUM Growth
+$4.76B
(-6%)
Cap. Flow
-$651M
Cap. Flow
% of AUM
-13.68%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
169
New
40
Increased
23
Reduced
18
Closed
45
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$128M |
| 2 |
Boston Scientific
BSX
|
$110M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
$70.5M |
| 5 |
Organogenesis Holdings
ORGO
|
$54.6M |
Top Sells
| 1 |
Nkarta
NKTX
|
$87.3M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$65.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$58.2M |
| 4 |
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
|
$56.1M |
| 5 |
DFHTU
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
|
$50.4M |
Sector Composition
| 1 | Healthcare | 70.89% |
| 2 | Consumer Discretionary | 0.23% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $241M | 5.06% | 17,224,000 +1,500,000 | +10% | +$21M |
|
|
2
Edgewise Therapeutics
EWTX
$1.51B
| $128M | 2.69% | +3,933,137 | New | +$128M |
|
3
Centene
CNC
$14.3B
| $127M | 2.67% | 1,985,619 -444,381 | -18% | -$28.4M |
|
|
4
Boston Scientific
BSX
$156B
| $110M | 2.32% | +2,857,000 | New | +$110M |
|
5
The Oncology Institute
TOI
$318M
| $104M | 2.19% | 10,460,000 +5,000,000 | +92% | +$49.8M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $88.6M | 1.86% | +579,248 | New | +$88.6M |
|
7
Biogen
BIIB
$19.4B
| $86.7M | 1.82% | 310,000 -138,000 | -31% | -$38.6M |
|
8
AdaptHealth
AHCO
$1.28B
| $83.7M | 1.76% | 2,277,871 +471,539 | +26% | +$17.3M |
|
|
CMAX
9
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $82.2M | 1.73% | 6,778,750 +3,360,000 | +98% | +$40.7M |
|
10
Pacira BioSciences
PCRX
$1.2B
| $81.7M | 1.72% | 1,164,973 +115,326 | +11% | +$8.08M |
|
11
Larimar Therapeutics
LRMR
$310M
| $75.2M | 1.58% | 5,144,539 | – | – |
|
|
12
Neurocrine Biosciences
NBIX
$13.8B
| $70.5M | 1.48% | +725,000 | New | +$70.5M |
|
13
Mirum Pharmaceuticals
MIRM
$3.71B
| $68.4M | 1.44% | 3,448,912 | – | – |
|
14
Revolution Medicines
RVMD
$7.1B
| $65.9M | 1.39% | 1,436,712 +40,329 | +3% | +$1.85M |
|
15
Cytokinetics
CYTK
$4.23B
| $59.6M | 1.25% | 2,561,000 +100,000 | +4% | +$2.33M |
|
16
Owens & Minor
OMI
$378M
| $58.2M | 1.22% | 1,549,000 +453,000 | +41% | +$17M |
|
|
AFIB
17
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $58.1M | 1.22% | 4,341,799 | – | – |
|
18
Zimmer Biomet
ZBH
$21B
| $57.1M | 1.2% | 357,000 +262,000 | +276% | +$41.9M |
|
|
19
Organogenesis Holdings
ORGO
$653M
| $54.6M | 1.15% | +2,995,638 | New | +$54.6M |
|
20
Molina Healthcare
MOH
$9.8B
| $54.2M | 1.14% | 231,776 +106,776 | +85% | +$25M |
|
21
Terns Pharmaceuticals
TERN
$609M
| $51.6M | 1.08% | +2,345,959 | New | +$51.6M |
|
22
Alphatec Holdings
ATEC
$2.35B
| $50.6M | 1.06% | 3,201,916 +1,201,916 | +60% | +$19M |
|
|
ORTX
23
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $50.5M | 1.06% | 6,949,416 | – | – |
|
|
OCDX
24
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $45.4M | 0.95% | +2,352,941 | New | +$45.4M |
|
25
Brookdale Senior Living
BKD
$1.83B
| $45.3M | 0.95% | 7,490,845 -3,532,620 | -32% | -$21.4M |
|